HIGHLIGHTS
- who: Report et al. from the Aventura Hospital and Medical Center, Aventura, USA Internal Medicine, Jinnah Medical and Dental College have published the paper: Review began 01/12/2023 Review ended 01/26/2023 Published 01/28/2023 u00a9 Copyright, in the Journal: (JOURNAL) of January/28,/2023
- what: Through these case series, the authors intended to examine the potential use of a CPM-based throat spray formulation, a drug with antiallergic, anti-inflammatory, and broad-spectrum antiviral effects, to alleviate the symptoms associated with COVID-19-induced AVP.
SUMMARY
A . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.